In den Dauen 6
53117 Bonn, Germany, de
Joerg W. Breitkopf
+49 (2226) 1596311
clinicalprojects international GmbH Announces Further Growth into New Therapeutic and Geographic Areas
CPI started offering clinical development services in 2007 as a young Clinical Research Organization (CRO) in intensive care medicine with a special focus on sepsis. In the interim, CPI has successfully expanded its clinical operations and regulatory services in further therapeutic areas across Europe. In addition to its core expertise in the management of phase II and phase III clinical trials, CPI further expanded its range of services to cater for observational studies beginning of 2009. The company's current clients include international (bio)pharmaceutical and medical device companies, and CPI's repeat business has been a major factor in driving the business forward.
Joerg W. Breitkopf, Managing Director of clinicalprojects international GmbH commented, "The year 2010 will be another very important year for the continuing development of the company. Our plans include geographic expansion into other European markets, and plans for Italy, Spain, and the UK in particular are very close to realization."
In January 2009, a communication about tentative merger plans with a USbased company could be read in a press release, but such plans did not come to fruition. Mr. Breitkopf commented,"CPI has both the infrastructure and the client base to further develop itself as an independent organization in 2010 and the future".
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.